The BTLAhigh group recruited a high proportion of CD4+ T cells, CD8+ T cells, Th1 cells, dendritic cells, macrophage, NK cells, and Th2 cells in primary and metastatic SKCM tissues in the cancer immunity cycle. The gene discussed is CD4; the disease is cancer.